Your browser doesn't support javascript.
loading
Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
Rommel, C; Clarke, B A; Zimmermann, S; Nuñez, L; Rossman, R; Reid, K; Moelling, K; Yancopoulos, G D; Glass, D J.
Afiliação
  • Rommel C; Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Science ; 286(5445): 1738-41, 1999 Nov 26.
Article em En | MEDLINE | ID: mdl-10576741
ABSTRACT
Extracellular signals often result in simultaneous activation of both the Raf-MEK-ERK and PI3K-Akt pathways (where ERK is extracellular-regulated kinase, MEK is mitogen-activated protein kinase or ERK kinase, and PI3K is phosphatidylinositol 3-kinase). However, these two signaling pathways were shown to exert opposing effects on muscle cell hypertrophy. Furthermore, the PI3K-Akt pathway was shown to inhibit the Raf-MEK-ERK pathway; this cross-regulation depended on the differentiation state of the cell Akt activation inhibited the Raf-MEK-ERK pathway in differentiated myotubes, but not in their myoblast precursors. The stage-specific inhibitory action of Akt correlated with its stage-specific ability to form a complex with Raf, suggesting the existence of differentially expressed mediators of an inhibitory Akt-Raf complex.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Músculo Esquelético / Proteínas Proto-Oncogênicas c-raf / Proteínas Quinases Ativadas por Mitógeno Limite: Animals Idioma: En Ano de publicação: 1999 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Músculo Esquelético / Proteínas Proto-Oncogênicas c-raf / Proteínas Quinases Ativadas por Mitógeno Limite: Animals Idioma: En Ano de publicação: 1999 Tipo de documento: Article